Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL - Test2 - elhamkhani - TriplyDB

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

http://www.wikidata.org/entity/Q24682139

about

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation Emerging Functions of RANKL in Lymphoid Tissues Tumor metastasis to bone Biology of RANK, RANKL, and osteoprotegerin LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 The gene for cherubism maps to chromosome 4p16.IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis Giant cell tumour of bone: morphological, biological and histogenetical aspects RANK is essential for osteoclast and lymph node development A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway Control of RANKL gene expression Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL Role of NADPH oxidase in formation and function of multinucleated giant cells Denosumab Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand Osteoimmunology: interactions of the bone and immune system Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL A novel member of the leukocyte receptor complex regulates osteoclast differentiation Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation Osteoclasts: what do they do and how do they do it?Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation The role of osteoprotegerin in arthritis Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis Bone loss. Factors that regulate osteoclast differentiation: an update.The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.The molecular mechanism of osteoclastogenesis in rheumatoid arthritis The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone RANK-RANKL signalling in cancer Role of EMT in Metastasis and Therapy Resistance The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review Caldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and function Host response mechanisms in periodontal diseases

P2860

Q21092154-1D8A5BB8-D329-477E-9B8B-CAC9A0CD8535 Q21131222-A5794F76-4A6F-4A32-924D-68102A31C5D0 Q21195416-9D079B93-6673-4AF3-9816-D4A343163128 Q21195419-40195906-9237-40D7-A1BC-4567A2BB864E Q24312907-7D4DBCB3-AE7A-4124-8629-774D38B5A515 Q24318438-B4F21269-A989-4516-B99F-09A4C7C5BC79 Q24537518-CEECAFE9-A43D-495E-B10D-D51787AC7035 Q24540306-86F68B14-A0BD-4A89-BF33-B5F5754B3E4F Q24563235-3205F067-444B-4CDA-B8C4-412DF8629F84 Q24595415-6C48B6C7-2139-4128-81C4-13E5A03335E2 Q24598872-ED5C32B0-AE6B-4E87-9F91-4EF6E1C44BE5 Q24599024-8E923773-01C7-41CA-9244-AD77897ED8D4 Q24619669-55E724EB-AD93-4468-BC29-9060DDFE3E0B Q24632345-81A57123-160B-49E5-87CE-CBCBE7D5E9FC Q24633426-3B68D3E4-95BC-474D-9C0F-A308F2B987BF Q24651938-1D9660DC-502B-4A66-AEB3-F2F9F125F56B Q24653311-0831B116-BA6F-49EA-9F18-88D0D0B19E21 Q24655113-76F5A9BD-97C9-44DB-8BF3-341A4D270096 Q24657159-0617B1F1-4F71-4966-BCF2-D75452E86C02 Q24658507-039DDC7E-B4FD-4878-9338-CBB3203A3BB2 Q24673624-E8E0AC70-5DBB-470F-9EEE-A71661213F99 Q24675157-3A3229D5-33FE-46C9-9BFD-ECBA28B38A9C Q24681552-811E4376-A68C-4044-B1DD-D60E7AD075E1 Q24683898-3D6FC38C-4B8E-45CB-A493-246C1C17742B Q24701798-8ED473F5-F7E0-4D05-ABDA-E4C4460AB007 Q24796088-45E6641C-7824-440F-8442-3FE4EC2C072B Q24797889-6EEE7843-B62C-4198-8A20-86E330B64644 Q24799753-B8FF7C88-725E-423C-BDA5-B30F4AA3BB7A Q24800726-FF82F108-0339-4964-A2BB-9C0D416BEBA1 Q24805142-3BC35328-F6B6-4DDA-84B1-D4A24358A282 Q24805207-DC08A95F-07F5-4424-AD55-8AA90A4A72E1 Q24806322-1FE01211-225B-412B-8E61-93F65641BD28 Q24816632-3BED801F-17B6-43A3-AEB6-96E232663651 Q26738435-C2BBA8BD-8A97-4C75-A05F-E408980A17B7 Q26747442-C76D8F60-D01C-413C-8959-11953D8982EB Q26772923-6323D84D-FAB7-4AD4-9FD4-589771931361 Q26773017-191CE7C9-F434-4537-8646-0011A5BF29AA Q26774874-36C575F2-F08D-4CE4-81CF-41A02AD24ABC Q26775406-0FC7D8AE-4D3C-4EFB-98CC-5817D3D7F23F Q26801846-3E01325F-AB84-4766-ACCA-B81F36FA98ED

P2860

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

http://www.wikidata.org/entity/Q24682139

description

1998 nî lūn-bûn

@nan

1998 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մարտին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

name

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@ast

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@en

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@nl

type

label

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@ast

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@en

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@nl

prefLabel

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@ast

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@en

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@nl

P1433

Q24682139-F2D9689F-C185-4A30-8B67-18D180FB53B3

P1476

Q24682139-9505B23B-154A-48D1-8043-6FFD114D7BDD

P2093

Q24682139-08D2ED26-71DE-4271-BCE2-CA20BE6E0E5D

Q24682139-1C42DC15-E15B-4FA5-8402-8CCF9E69155D

Q24682139-22358FF0-4DF3-41EF-8F59-85FD9B3BE706

Q24682139-257AB529-468B-45B9-BF9C-D24D08686523

Q24682139-310A7442-EA47-48B3-A722-99ECC38E7434

Q24682139-37CDABC3-144D-4D8F-99F0-904E442382DB

Q24682139-625D284A-B19A-4A75-9086-B2C55F00F8F0

Q24682139-6A498463-E683-4653-ABBC-F77C34AA947F

Q24682139-7B5B3EC2-B5B2-424E-955D-52BA1CB333DF

Q24682139-80D11061-A5EE-4FA4-9971-E3334F2A3407

P2860

Q24682139-07731220-94B6-402E-A170-C75914157A17

Q24682139-0F512D08-5A13-4E12-BDD7-D4E78E6CA918

Q24682139-1829CB73-19E7-4AC4-97EE-CEB98E63C32F

Q24682139-2348EBA1-3C38-49F1-A0C0-C8AEE6AF9CE1

Q24682139-247D8DAB-5662-4101-B259-DC52089FC6C2

Q24682139-2DC6AAE3-E685-4D79-80DC-8BF98EB9E1D7

Q24682139-3027A8EC-9390-4BE2-B95B-238BFE4FBC35

Q24682139-34C81689-051D-4339-8DFF-E9C358F27B9C

Q24682139-5125AF37-BFD9-4794-A973-FFE884C1B2F5

Q24682139-6027D2D9-5377-44BD-A350-A8F2EC7FEF78

P304

Q24682139-C0EC7B3E-CDCE-4953-987A-7CE7DE41D9E2

P31

Q24682139-D8DD2FCE-6405-4D35-B552-A76D54B733E7

P3181

Q24682139-0F8FE7D8-9FB2-4B6F-AD91-3234945662E9

P356

Q24682139-40DE0151-29D9-4E1F-8567-190FDC1789E1

P407

Q24682139-B9F28A5E-2B5A-4B1B-9CD4-400CFBF02741

P433

Q24682139-252D5A53-FA8A-47C1-8571-9D9193D640A6

P478

Q24682139-29FF0BCB-C73C-4B93-9DEE-C876598DB07E

P577

Q24682139-DE8FBD4A-DE75-4EDD-A105-B30077BB4F18

P5875

Q24682139-ABAD4B6E-C37B-4420-B6D0-B169C4D0C621

P698

Q24682139-746D7407-DC9D-4F5C-8961-462CDFC56BA9

P932

Q24682139-8FA3CB3A-2B4C-4ACC-96D1-908B13579A70

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL

@en

P2093

A Murakami

http://www.w3.org/2001/XMLSchema#string

A Tomoyasu

http://www.w3.org/2001/XMLSchema#string

E Tsuda

http://www.w3.org/2001/XMLSchema#string

H Yasuda

http://www.w3.org/2001/XMLSchema#string

K Higashio

http://www.w3.org/2001/XMLSchema#string

K Yamaguchi

http://www.w3.org/2001/XMLSchema#string

K Yano

http://www.w3.org/2001/XMLSchema#string

M Goto

http://www.w3.org/2001/XMLSchema#string

M Kinosaki

http://www.w3.org/2001/XMLSchema#string

N Nakagawa

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors

Modulation of osteoclast differentiation.

P304

3597-602

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

684199

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.95.7.3597

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235610836

http://www.w3.org/2001/XMLSchema#string

P698

9520411

http://www.w3.org/2001/XMLSchema#string

P932

19881

http://www.w3.org/2001/XMLSchema#string